rs7129781

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_024514.5(CYP2R1):​c.225+1110A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0836 in 985,164 control chromosomes in the GnomAD database, including 3,872 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.10 ( 1041 hom., cov: 31)
Exomes 𝑓: 0.080 ( 2831 hom. )

Consequence

CYP2R1
NM_024514.5 intron

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -0.338

Publications

15 publications found
Variant links:
Genes affected
CYP2R1 (HGNC:20580): (cytochrome P450 family 2 subfamily R member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008]
PDE3B (HGNC:8779): (phosphodiesterase 3B) Enables 3',5'-cyclic-nucleotide phosphodiesterase activity. Involved in negative regulation of angiogenesis; negative regulation of cell adhesion; and negative regulation of lipid catabolic process. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2R1NM_024514.5 linkc.225+1110A>G intron_variant Intron 1 of 4 ENST00000334636.10 NP_078790.2 Q6VVX0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2R1ENST00000334636.10 linkc.225+1110A>G intron_variant Intron 1 of 4 1 NM_024514.5 ENSP00000334592.5 Q6VVX0

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15566
AN:
151960
Hom.:
1041
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.0980
Gnomad AMR
AF:
0.0652
Gnomad ASJ
AF:
0.0505
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.0774
Gnomad FIN
AF:
0.0426
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0699
Gnomad OTH
AF:
0.103
GnomAD4 exome
AF:
0.0802
AC:
66777
AN:
833086
Hom.:
2831
Cov.:
29
AF XY:
0.0797
AC XY:
30647
AN XY:
384712
show subpopulations
African (AFR)
AF:
0.193
AC:
3051
AN:
15782
American (AMR)
AF:
0.0508
AC:
50
AN:
984
Ashkenazi Jewish (ASJ)
AF:
0.0615
AC:
317
AN:
5152
East Asian (EAS)
AF:
0.153
AC:
556
AN:
3630
South Asian (SAS)
AF:
0.0764
AC:
1258
AN:
16462
European-Finnish (FIN)
AF:
0.0580
AC:
16
AN:
276
Middle Eastern (MID)
AF:
0.0704
AC:
114
AN:
1620
European-Non Finnish (NFE)
AF:
0.0776
AC:
59144
AN:
761880
Other (OTH)
AF:
0.0832
AC:
2271
AN:
27300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3041
6083
9124
12166
15207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3078
6156
9234
12312
15390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15592
AN:
152078
Hom.:
1041
Cov.:
31
AF XY:
0.101
AC XY:
7487
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.185
AC:
7675
AN:
41462
American (AMR)
AF:
0.0651
AC:
995
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0505
AC:
175
AN:
3468
East Asian (EAS)
AF:
0.161
AC:
831
AN:
5166
South Asian (SAS)
AF:
0.0775
AC:
373
AN:
4816
European-Finnish (FIN)
AF:
0.0426
AC:
452
AN:
10602
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.0699
AC:
4752
AN:
67978
Other (OTH)
AF:
0.104
AC:
218
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
688
1376
2063
2751
3439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0837
Hom.:
2215
Bravo
AF:
0.110
Asia WGS
AF:
0.133
AC:
463
AN:
3478

ClinVar

Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Pulmonary disease, chronic obstructive, susceptibility to Other:1
Jul 05, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.2
DANN
Benign
0.68
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7129781; hg19: chr11-14912417; API